NCT04175327View on ClinicalTrials.gov

Prospective and Non-randomized Registry of CardioCel 3D

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

August 28, 2020

Primary Completion Date

November 30, 2025

Study Completion Date

March 31, 2026

Conditions
Intracardiac and Septal DefectsValve and Anulus RepairGreat Vessel ReconstructionPeripheral Vessel ReconstructionSuture Line Buttressing
Interventions
DEVICE

CardioCel implantation

treatment of intracardiac defects; treatment of septal defects; valve and annulus repair; great vessel reconstruction; peripheral vascular reconstruction; suture line buttressing

Trial Locations (6)

10126

A.O.U. Città della Salute e della Scienza, Turin

20097

Policlinico San Donato, San Donato Milanese

28041

"Hospital Universitario Doce de Octubre", Madrid

04289

Heart Center Leipzig, Leipzig

Unknown

Bristol Children's Hospital and the Heart Institute, Bristol

NE7 7DN

The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle

Sponsors

Lead Sponsor

LeMaitre Vascular
All Listed Sponsors
collaborator

Factory CRO for Medical Devices B.V.

OTHER

lead

LeMaitre Vascular

INDUSTRY

NCT04175327 - Prospective and Non-randomized Registry of CardioCel 3D | Biotech Hunter | Biotech Hunter